PCN69 Cost-Effectiveness Analysis of Aromatase Inhibitors and Tamoxifen As an Adjuvant Therapy in Postmenopausal Women with Early-Stage Hormone Receptor Positive Breast Cancer
Jun 1, 2012, 00:00
10.1016/j.jval.2012.03.1186
https://www.valueinhealthjournal.com/article/S1098-3015(12)01251-X/fulltext
Title :
PCN69 Cost-Effectiveness Analysis of Aromatase Inhibitors and Tamoxifen As an Adjuvant Therapy in Postmenopausal Women with Early-Stage Hormone Receptor Positive Breast Cancer
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(12)01251-X&doi=10.1016/j.jval.2012.03.1186
First page :
A220
Section Title :
Cancer
Open access? :
No
Section Order :
711